Pi Health Cancer Hospital

Facebook Twitter Youtube Instagram Linkedin
Book Online consultation
Dr. Venugopal Arroju - Best Medical Oncologist and Hemato-Oncologist

Dr. Venugopal Arroju

Clinical Director & HOD Medical Oncology Senior Consultant Medical Oncologist & Hemato-Oncologist

Qualifications 

MD (General Medicine), DM (Medical Oncology), 
MRCP – SCE Medical Oncology (UK), ECMO (Switzerland).

Experience 

15+ years

Call Now

Book Appointment

Dr. Venugopal Arroju, the Clinical Director, and Head of Department at Pi Health Cancer Hospital, brings extensive expertise and dedication to the team. He holds an MD in General Medicine, a DM in Medical Oncology, and MRCP credentials from the UK. 

With over 15+ years of experience, including roles at Apollo Hospitals and Yashoda Hospital, Dr. Venugopal has made significant contributions to cancer treatment and research. Known for his compassionate, patient-focused approach, he specializes in immunotherapy, targeted therapy, and precision oncology, particularly for lung, breast, gynecological, and colorectal cancers. 

Dr. Venugopal’s research is widely recognized, with numerous publications and active participation in international conferences. He is also a member of ASCO, ESMO, and ISMPO. Under Dr. A. Venugopal’s leadership, Pi Health Cancer Hospital offers world-class cancer care, bringing hope and innovative treatment solutions to patients.

  • 2013-2016: DM (Medical Oncology) from Kidwai Memorial Institute of Oncology, RGUHS, Bangalore 
  • 2010-2013: MD (General Medicine) from M.S. Rajamaiah  Medical College, RGUHS, Bangalore 
  •   Effective Management of Solid Tumors and Hematological Malignancies
  •   Chemotherapy Administration
  •   Autologous Bone Marrow Transplantation
  •   Routine procedures like Bone Marrow Aspiration and Biopsy, Lumbar Puncture, and central line insertion

Clinical Trials and GCP:

  • Trained in Good Clinical Practices (GCP).
  • Conducted a Phase III Trial involving TNBC Patients.
  • Participated in a Phase III Trial focusing on early Breast Cancer with Her 2 Positive status.
  • American Society of Clinical Oncology (ASCO)
  • European Society of Clinical Oncology (ESMO)
  • Indian Society of Medical and Pediatric Oncology (ISMPO)
  • Indian Cooperative Oncology Network (ICON)
  • Adrenal Cortical Cancer from a Regional Cancer Center in South India
  • Primary Parotid Lymphoma from a Regional Cancer Center in South India
  • Ovarian Non-Hodgkin’s Lymphoma from a Regional Cancer Center in South India
  • A randomized prospective study comparing the efficacy and safety of olanzapine versus aprepitant in highly emetogenic chemotherapy: A study from a regional Cancer Center, India
  • Attended ESMO in Paris
  • Participated in ASKO-2023 in Chicago
  • Was a part of ASH-2018 in San Diego
  • Attended SPEAK 2014 in Mumbai.
  • Participated in VICON 2014 at Vydehi Institute of Medical Sciences and Research Centre, Bangalore.
  • Engaged in the Pediatric Oncology CME Programme at Shankara Cancer Hospital, Bangalore.
  • Joined the COPE Meeting 2015 in Chennai.
  • Attended SPEAK 2015 in Mumbai.
  • Participated in the COPE Meeting 2016 in Chennai.
  • Joined the Young Medical Oncologists Meet in Hyderabad.
  • Participated in the Advances in Radiation Treatment- IMRT and beyond.
  • Engaged in the CME on Gastric and OG Junction Cancers: Update.

Brief Profile

Dr. A. Venugopal, the Clinical Director, and Head of Department at Pi Health Cancer Hospital, brings extensive expertise and dedication to the team. He holds an MD in General Medicine, a DM in Medical Oncology, and MRCP credentials from the UK. 

With over 20 years of experience, including roles at Apollo Hospitals and Yashoda Hospital, Dr. Venugopal has made significant contributions to cancer treatment and research. Known for his compassionate, patient-focused approach, he specializes in immunotherapy, targeted therapy, and precision oncology, particularly for lung, breast, gynecological, and colorectal cancers. 

Dr. Venugopal’s research is widely recognized, with numerous publications and active participation in international conferences. He is also a member of ASCO, ESMO, and ISMPO. Under Dr. A. Venugopal’s leadership, Pi Health Cancer Hospital offers world-class cancer care, bringing hope and innovative treatment solutions to patients.

 

  • 2013-2016: DM (Medical Oncology) from Kidwai Memorial Institute of Oncology, RGUHS, Bangalore 
  • 2010-2013: MD (General Medicine) from M.S. Rajamaiah  Medical College, RGUHS, Bangalore 
  •  Effective Management of Solid Tumors and Hematological Malignancies
  •  Chemotherapy Administration
  • Autologous Bone Marrow Transplantation
  • Routine procedures like Bone Marrow Aspiration and Biopsy, Lumbar Puncture, and central line insertion

Clinical Trials and GCP:

  • Trained in Good Clinical Practices (GCP).
  • Conducted a Phase III Trial involving TNBC Patients.
  • Participated in a Phase III Trial focusing on early Breast Cancer with Her 2 Positive status.
  • American Society of Clinical Oncology (ASCO)
  • European Society of Clinical Oncology (ESMO)
  • Indian Society of Medical and Pediatric Oncology (ISMPO)
  • Indian Cooperative Oncology Network (ICON)
  • Adrenal Cortical Cancer from a Regional Cancer Center in South India
  • Primary Parotid Lymphoma from a Regional Cancer Center in South India
  • Ovarian Non-Hodgkin’s Lymphoma from a Regional Cancer Center in South India
  • A randomized prospective study comparing the efficacy and safety of olanzapine versus aprepitant in highly emetogenic chemotherapy: A study from a regional Cancer Center,India
  • Attended ESMO in Paris
  • Participated in ASKO-2023 in Chicago
  • Was a part of ASH-2018 in San Diego
  • Attended SPEAK 2014 in Mumbai.
  • Participated in VICON 2014 at Vydehi Institute of Medical Sciences and Research Centre, Bangalore.
  • Engaged in the Pediatric Oncology CME Programme at Shankara Cancer Hospital, Bangalore.
  • Joined the COPE Meeting 2015 in Chennai.
  • Attended SPEAK 2015 in Mumbai.
  • Participated in the COPE Meeting 2016 in Chennai.
  • Joined the Young Medical Oncologists Meet in Hyderabad.
  • Participated in the Advances in Radiation Treatment- IMRT and beyond.
  • Engaged in the CME on Gastric and OG Junction Cancers: Update
Previous
Next
See More videos

Awards & Gallery

FAQS

1. Why do patients frequently visit Dr. A. Venugopal?

Patients frequently visit Dr. A. Venugopal for expert guidance and personalized care in medical oncology, including the management of solid tumors, hematological malignancies, and chemotherapy administration.

2. What are Dr. A. Venugopal's educational qualifications?

Dr. A. Venugopal holds an MD in General Medicine, a DM in Medical Oncology, and MRCP credentials in Medical Oncology. His extensive training and academic background make him a highly sought-after specialist in the field.

3. What does Dr. A. Venugopal specialize in?

Dr. A. Venugopal specializes in medical oncology, with a focus on the diagnosis, treatment, and management of various cancers, including solid tumors and hematological malignancies.

4. Where does Dr. A. Venugopal practice?

Dr. A. Venugopal practices at Pi Health Cancer Hospital in Hyderabad, India, where he serves as the Head of the Department and Senior Consultant in Medical Oncology.

5. How can I book an appointment with Dr. A. Venugopal - Best Medical Onclogost and Hemato-Oncologist?

You can book an appointment with Dr. A. Venugopal by contacting Pi Health Cancer Hospital directly or through our website, pihealthcancerhospital.com. 

6. How many years of experience does Dr. A. Venugopal have?

Dr. A. Venugopal has over 15 years of experience in the field of medical oncology, during which he has provided compassionate care and innovative treatment solutions to patients battling cancer.